Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2022-01 Issue:1 Volume:10 Page:26-34
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Naccache Jean-Marc,Jouneau Stéphane,Didier Morgane,Borie Raphaël,Cachanado Marine,Bourdin Arnaud,Reynaud-Gaubert Martine,Bonniaud Philippe,Israël-Biet Dominique,Prévot Grégoire,Hirschi Sandrine,Lebargy François,Marchand-Adam Sylvain,Bautin Nathalie,Traclet Julie,Gomez Emmanuel,Leroy Sylvie,Gagnadoux Frédéric,Rivière Frédéric,Bergot Emmanuel,Gondouin Anne,Blanchard Elodie,Parrot Antoine,Blanc François-Xavier,Chabrol Alexandre,Dominique Stéphane,Gibelin Aude,Tazi Abdellatif,Berard Laurence,Brillet Pierre Yves,Debray Marie-Pierre,Rousseau Alexandra,Kerjouan Mallorie,Freynet Olivia,Dombret Marie-Christine,Gamez Anne-Sophie,Nieves Ana,Beltramo Guillaume,Pastré Jean,Le Borgne-Krams Aurélie,Dégot Tristan,Launois Claire,Plantier Laurent,Wémeau-Stervinou Lidwine,Cadranel Jacques,Chenivesse Cécile,Valeyre Dominique,Crestani Bruno,Cottin Vincent,Simon Tabassome,Nunes Hilario

Funder

Roche

Ministere de la Sante et des Solidarites

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference25 articles.

1. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report;Collard;Am J Respir Crit Care Med,2016

2. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias;Churg;Am J Surg Pathol,2007

3. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy;Parambil;Chest,2005

4. Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis;Oda;Respir Res,2014

5. Clinical predictors and explant lung pathology of acute exacerbation of idiopathic pulmonary fibrosis;Dotan;ERJ Open Res,2020

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential;Bioorganic & Medicinal Chemistry;2024-09

2. Imaging Pulmonary Fibrosis and Treatment Efficacy In Vivo with Autotaxin-Specific PET Ligand [¹⁸F]ATX-1905;Molecular Pharmaceutics;2024-08-26

3. Value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in acute exacerbation of fibrosing interstitial lung disease: an individualized treatment protocol based on microbiological evidence;BMC Pulmonary Medicine;2024-08-20

4. Treatment of acute exacerbations of interstitial lung diseases with corticosteroids: Evidence?;Respirology;2024-07-03

5. Acute exacerbation of idiopathic pulmonary fibrosis a narrative review primary focus on treatments;Journal of Thoracic Disease;2024-07